The ECFS-CTN cannot guarantee that the information provided here is comprehensive. Please go to the link for detailed and up-to-date information on study background, eligibility criteria, study design, outcome measures, study status, participating sites, sponsor contact information and timelines.

You can also contact the CTN coordinating centre for additional information: (link sends e-mail)

Study Name on (link is external)
Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation (KONTINUE)
Study DrugIvacaftor (VX770)
Type of Study DrugCFTR Modulation
Study TitleA Phase 3, Two-Arm, Rollover Study to Evaluate the Safety of Long Term Ivacaftor Treatment in Subjects 6 Years of Age and Older with Cystic Fibrosis and a Non-G551D CFTR Mutation
Study Phase3
Study SponsorVertex

Link on (link is external) (link is external)

Participating ECFS-CTN sitesBelgium: Leuven
France: Lyon, Montpellier, West-Paris (Debré)
UK: Belfast
Age6 years and older